CRL4A(CRBN) E3 ubiquitin ligase restricts BK channel activity and prevents epileptogenesis

Area of Science:

• Neuroscience
• Molecular Biology
• Biochemistry

Background:

• Ion channels are crucial for regulating membrane excitation and neurological function.
• Mutations in ion channels are linked to neurological disorders like epilepsy.
• Post-translational modifications fine-tune ion channel activity, but are less understood than protein structure and function.

Purpose of the Study:

• To investigate the role of E3 ubiquitin ligase CRL4A(CRBN) in regulating large conductance, Ca(2+)- and voltage-activated K(+) (BK) channels.
• To elucidate the impact of BK channel ubiquitination on neuronal excitability and epilepsy.

Main Methods:

• Utilized biochemical assays to identify CRL4A(CRBN) as an E3 ubiquitin ligase targeting BK channels.
• Investigated the effect of CRL4A(CRBN) inactivation on BK channel localization and activity using cell models.
• Employed mouse models with genetic mutations or pharmacological inhibition of CRL4A(CRBN) to assess seizure sensitivity and epilepsy development.
• Examined the therapeutic potential of blocking BK channels in a seizure model.

Main Results:

• CRL4A(CRBN) polyubiquitinates BK channels, leading to their retention in the endoplasmic reticulum (ER).
• Inactivation of CRL4A(CRBN) results in deubiquitination, ER release, and enhanced BK channel activity at the plasma membrane.
• Mice lacking functional CRL4A(CRBN) in the brain exhibit increased seizure susceptibility, which is mitigated by BK channel blockers.
• Aged mutant mice develop spontaneous epilepsy, indicating a role for CRL4A(CRBN) in preventing epileptogenesis.

Conclusions:

• Ubiquitination of BK channels by CRL4A(CRBN) is a critical regulatory step controlling their cell surface expression.
• This regulatory mechanism prevents excessive neuronal excitability and the development of epilepsy.
• Targeting the CRL4A(CRBN)-BK channel axis offers a potential therapeutic strategy for epilepsy.